Aspira Women’s Health Inc. Notes Reduction
Aspira Women’s Health Inc. (AWHL) reported Notes Reduction of $7.75 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesReduction · last filed 2023-10-26
- Aspira Women’s Health Inc. notes reduction for the quarter ending 2021-12-31 was $0.00.
- Aspira Women’s Health Inc. notes reduction for the quarter ending 2021-09-30 was $0.00.
- Aspira Women’s Health Inc. notes reduction for fiscal 2022 was $7.75M, a 670.58% increase from fiscal 2021.
- Aspira Women’s Health Inc. notes reduction for fiscal 2021 was $1.01M.
| Period end | Notes Reduction 3 month | Notes Reduction 6 month | Notes Reduction 9 month | Notes Reduction 12 month |
|---|---|---|---|---|
| 2022-12-31 | $7.75M 10-K · filed 2023-03-30 | |||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-10-26 | $0.00 derived: sum of 2 quarters · filed 2023-10-26 | $1.01M 10-K/A · filed 2023-10-26 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.01M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $1.01M 10-Q · filed 2022-08-10 |